DOCSLIB.ORG

Pyruvate Dehydrogenase Complex - Correlation Between Structure and Function

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pyruvate Dehydrogenase Complex - Correlation Between Structure and Function PYRUVATE DEHYDROGENASE COMPLEX - CORRELATION BETWEEN STRUCTURE AND FUNCTION AGNIESZKA SEYDA A thesis submitted in conforrnity with the requirements for the degree of Doctor of Philosophy Graduate Department of Biochernistry University of Toronto @Copyright by Agnieszka Seyda National Library Bibliothèque nationale ($1 of Canada du Canada Acquisitions and Acquisitions et Bibliographie Sewices selvices bibliographiques 395 WeUington Street 395. rue Wellington Ottawa ON Ki A ON4 Ottawa ON K 1A ON4 Canada Canada The author has granted a non- L'auteur a accordé une licence non exclusive licence allowing the exclusive pemettant à la National Library of Canada to Bibliothèque nationale du Canada de reproduce, loan, distribute or sel reproduire, prêter, distribuer ou copies of ths thesis in microform, vendre des copies de cette thèse sous paper or electronic formats. la fome de rnicrofiche/film, de reproduction sur papier ou sur foxmat électronique. The author retains ownership of the L'auteur conserve la propriété ch copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fiom it Ni la thèse ni des extraits substantiels may be printed or othewise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits sans son permission. autorisation. ACKNOWLEDGEMENTS I wish to express my thanks and gratitude to Dr. Brian Robinson for his support, assistance and most of al1 patience during the entire course of this degree. His stimulating discussions always served to heighten my enthusiasm to cary out the research and his knowledge made me realize that there will never be the end to my education. I would like to thank the rnembers of my Ph.D. committee, Dr. John Callahan and Dr. James Ellis for al1 their encouragement. support and constructive criticism. 1 would also like to thank my [ab mates. some of who deserve a special mention. Dr. Mingfu Ling and Dr. Sandeep Raha were especially critical to my science education. never too busy to help out as well as talk about science. Finally, 1 would like to thank my family. My parents have been an endless source of support (both emotionai and financial). They always told me not to be afraid to take risk in life and remove limits from my dreams. I would also like to thank my husband Roberto who taught me that it is not important what you do but why you do it. PYRUVATE DEHYDROGENASE COMPLEX - CORRELATION BETWEEN STRUCTURE AND FUNCTION Doctor of Philosophy, 2001 Agnieszka Seyda Department of Biochemistry, University of Toronto ABSTRACT Human PDH complex deficiency is an extremely heterogenous disease in its presentation. Very little correlation between clinical course and molecular characteristics has becn established SJ far. In order to more accurately define the structure of the complex. mutationai analyses were perfomed on its two components, PDH-E,aand protein X. A series of PDH- E,a deletion mutants was construcied and expressed in a ce11 line with zero PDH complex activity due to a nul1 E,a allele (the no ce11 line). Sequential deletion of the C-terminus by 1,2,3 and 4 amino acids resulted in PDH complex activities of 100, 60. 30 and 14% compared to wild-type Ela expressed in PDH complex deficient cells. In addition the somatic and the testis-specific PDH-E,a human isoforms were determined to be biochemically equivalent. Furthermore. a series of PDH-Ela histidine mutants (H63.H84. H92 and H263) was constructed and expressed in the d' cell line. H63 and H263 were shown to be essential for the PDH complex activity. while Hg2 was implicated in the PDH-Ela,& heterotetramer formation and/or stability. A novel PDH-Ela mutation R 14 1 L was characterized in a male patient and it was found in about 75% of the studied DNA derived fom various tissues (fibroblasts, liver and muscle). This scenario would indicate a case of E,a somatic mosaicism. The R141L mutation is a severe one and it must have occurred in iii one of the E,a alleles during early embryogenesis. To gain further insight into the nature and function of the domains of the human protein X. two artificially created variants. K37E and S422H as well as the wild-type were expressed in SV40-immortalized protein X-deficient and EL-deficient human skin fibroblasts. The former mutant does not carry the lipoic acid moiety; the latter mutant was designed to investigate the possibility that protein X could exhibit an intrinsic rransacetylase activity. None of the expressed protein X variants had an effect on the specific activity of the PDH complex. suggesting that the human protein X plays a purely structural role. A novel syndrome affecting multiple mitochondrial functions was described and localized by microcell-mediated transfer to chromosornr 2p 14-2p 13. TABLE OF CONTENTS ACKNOWLEDGEMENTS ii ABSTRACT iii TABLE OF CONTENTS v LIST OF FIGURES viii LIST OF TABLES X ABBREVIATIONS xi NOTICE xiii CHAPTER 1 INTRODUCTION What are mitochondria 2-0x0 acid dehydrogenases - overview The pyruvate dehydrogenase complex El Thiamin metabolism E,a - the testis-specific isoform E, and protein X ~lpicacid metabolisrn E3 Regulation of the PDH complex Extracellular regulation of the PDH complex Import into rnitochondria Commercial uses of 2-0x0 acid dehydrogenases Mutational studies of the PDH-E,a Expression systems The metabolon Objectives of the thesis CHAPTER 2 SEQUENTIAL DELETION OF C-TERMINAL AMINO ACIDS OF THE Ela COMPONENTS OF THE PDH COMPLEX LEADS TO WDUCED STEADY-STA'E LEVELS OF FUNCTIONAL Ela$, TETRAMERS: IMPLICATIONS FOR PATIENTS WITH PDH DEFICIENCY 2.1 Introduction 2.2 Materials and Methods 2.3 Results 2.4 Discussion 2.5 Acknowledgements CHAPTER 3 FUWCTIONAL EXPRESSION OF FOUR PDH-E,a RECOMBINANT HISTIDINE iMUTANTS IN A HUMAN FIBROBLAST CELL LINE WITH ZERO ENDOGENOUS PDH COMPLEX ACTIVITY 3.1 Introduction 3.2 Materials and Methods 3.3 Results 3.4 Discussion 3.5 Acknowledgements CHAPTER 4 EXPRESSION AND FUNCTIONAL CHARACTERIZATION OF THE HUMAN PROTEIN X VARIANTS IN SV40-IMMORTALIZED PROTEIN X-DEFICIENT AND E2-DEFICIENT HUMAN SKIN FIBROBLASTS 4.1 Introduction 4.2 Materials and Methods 4.3 Results and Discussion 4.4 Acknowledgements CHAPTER 5 A CASE OF PDH-Ela MOSAICISM IN A MALE PATIENT WITH SEVERE METABOLIC LACTIC ACIDOSIS 5.1 Introduction 5.2 Materials and Methods 5.3 Results 5 -4 Discussion 5.5 Acknowledgements CHAPTER 6 A NOVEL SYNDROME AFFECTING MULTIPLE bIITOCHONDRIAL FUNCTIONS, LOCATED BY MICROCELL-MEDIATED TRANSFER TO CHROMOSOME 2p14-2p13 6.1 Introduction 6.2 Case report 6.3 Materials and Methods 6.4 Results 6.5 Discussion CHAPTER 7 DISCUSSION AND FUTURE DIRECTIONS 7.1 Cornparison of PDHC with BCKDHC and OGDHC 14 1 7.2 Cornparison of the E, forms 142 7.3 Protein X 153 7.4 Multiple rnitochondrial enzyme disorders 156 7.5 Future directions 157 REFERENCES 159 vii LIST OF FIGURES CHAPTER 1 Schematic drawing of a rnitochondrion Position of the pyruvate dehydrogenase complex (PDHC) within cellular metabolism (A), Reaction sequence of PDHC (B) The chernical stmcture of thiamin diphosphate in its ylid form (A). proposed mechanism of ThDP-assisted decarboxylation of pyruvate by human El (B) Schematic outline of thiamin rnetabolism in yeast The domain structure of the acety! transferase core enzyme From E. di,mammals and yeast (A) and the mammalian/yeast protein X (B) The structure of the lipoyl domain from A. vinelandii The last step of lipoic acid synthesis carried out by lipoate synthase Schematic drawing of the active site of A. vinelandii E3 (A). proposed reaction of E3 (B) The control of phosphorylation-dephosphorylation of py nivate dehydrogenase by various effectors Schematic diagram showing mitoc hondrial cal' uptake sites in juxtaposition to the IP3-sensitive ca2+release channrl Protein import pathways into mitochondria Alignrnent of 6 Eiasequences (A); Alignment of 6 El sequences CHAPTER 2 2.1 Westem blot analysis of cultured skin fibroblasts (A), and lymphoblasts (B) derived from patients with ElaC-terminal deietions 2.2 Sequencing of plasmids containing PCR products of PDH-Ela cDNA derived from patients with E!a C-terminal de letions 2.3 Western blot analysis of the no celi line as well as the parental and control ceil lines 2.4 Westem blot analysis of plasmid expression of the wild-type and variant PDH-Ela 2.5 Quantitative RT-PCR specifically designed to pick up the exogenous but not the endogenous Eia mRNA. performed on wild-type Ela (A), Al variant (B) and A4 variant (C) 2.6 In vitro import of hurnan precursor PDH-Ela viii CHAPTER 3 Western blot analysis of plasmid expression of the wild-type and variant PDH-E1 a RT-PCRspecifically designed to generate a signal from the exogenous but not the endogenous Ela mRNA, performed on wild-type Ela(WT), the xo ce11 line, as well as H92D and H92N E ,avariants In vitro import of hurnan precursor PDH-Ela CHAPTER 4 Western blot analysis of plasrnid expression of the wiid-type and variant protein X peptides CHAPTER 5 Sequencing of plasmid clones containing PCR products amplified frorn the patient's cDNA Tissue distribution of mutated vs wild-type alleles of PDH-E la Western blot analysis of plasmid expression of the mutant R14 1 L and wild-type PDH-Elain the no ce11 line CHAPTER 6 Western blot analysis of the endogenous expression of the pynivate dehydrogenase complex (A). selected ho10 bc 1 complex proteins (B). and the bcl complex iron-sulphur protein ISP (C) 134 Ideograrn of human chromosome 2 showing the results of exclusion and deletion mapping for the rnitochondrial mulitenzyme de ficiency phenotype 135 CHAPTER 7 Functional motifs of PDH-Ela 154 LIST OF TABLES CHAPTER 2 Total PDH complex activities recorded and averaged for PDH-Ela variants transfected into the no ce11 CHAPTER 3 Mean total PDH complex activities given 2 SEM for controls.
Load more

Recommended publications
  • Mt-Atp8 Gene in the Conplastic Mouse Strain C57BL/6J-Mtfvb/NJ on the Mitochondrial Function and Consequent Alterations to Metabolic and Immunological Phenotypes
    From the Lübeck Institute of Experimental Dermatology of the University of Lübeck Director: Prof. Dr. Saleh M. Ibrahim Interplay of mtDNA, metabolism and microbiota in the pathogenesis of AIBD Dissertation for Fulfillment of Requirements for the Doctoral Degree of the University of Lübeck from the Department of Natural Sciences Submitted by Paul Schilf from Rostock Lübeck, 2016 First referee: Prof. Dr. Saleh M. Ibrahim Second referee: Prof. Dr. Stephan Anemüller Chairman: Prof. Dr. Rainer Duden Date of oral examination: 30.03.2017 Approved for printing: Lübeck, 06.04.2017 Ich versichere, dass ich die Dissertation ohne fremde Hilfe angefertigt und keine anderen als die angegebenen Hilfsmittel verwendet habe. Weder vorher noch gleichzeitig habe ich andernorts einen Zulassungsantrag gestellt oder diese Dissertation vorgelegt. ABSTRACT Mitochondria are critical in the regulation of cellular metabolism and influence signaling processes and inflammatory responses. Mitochondrial DNA mutations and mitochondrial dysfunction are known to cause a wide range of pathological conditions and are associated with various immune diseases. The findings in this work describe the effect of a mutation in the mitochondrially encoded mt-Atp8 gene in the conplastic mouse strain C57BL/6J-mtFVB/NJ on the mitochondrial function and consequent alterations to metabolic and immunological phenotypes. This work provides insights into the mutation-induced cellular adaptations that influence the inflammatory milieu and shape pathological processes, in particular focusing on autoimmune bullous diseases, which have recently been reported to be associated with mtDNA polymorphisms in the human MT-ATP8 gene. The mt-Atp8 mutation diminishes the assembly of the ATP synthase complex into multimers and decreases mitochondrial respiration, affects generation of reactive oxygen species thus leading to a shift in the metabolic balance and reduction in the energy state of the cell as indicated by the ratio ATP to ADP.
    [Show full text]
  • Mitochondrial Complex III Deficiency Associated with a Homozygous Mutation in UQCRQ
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector REPORT Mitochondrial Complex III Deficiency Associated with a Homozygous Mutation in UQCRQ Ortal Barel,1 Zamir Shorer,2 Hagit Flusser,2 Rivka Ofir,1 Ginat Narkis,1 Gal Finer,1 Hanah Shalev,2 Ahmad Nasasra,2 Ann Saada,3 and Ohad S. Birk1,4,* A consanguineous Israeli Bedouin kindred presented with an autosomal-recessive nonlethal phenotype of severe psychomotor retarda- tion and extrapyramidal signs, dystonia, athetosis and ataxia, mild axial hypotonia, and marked global dementia with defects in verbal and expressive communication skills. Metabolic workup was normal except for mildly elevated blood lactate levels. Brain magnetic resonance imaging (MRI) showed increased density in the putamen, with decreased density and size of the caudate and lentiform nuclei. Reduced activity specifically of mitochondrial complex III and variable decrease in complex I activity were evident in muscle biopsies. Homozygosity of affected individuals to UQCRB and to BCSIL, previously associated with isolated complex III deficiency, was ruled out. Genome-wide linkage analysis identified a homozygosity locus of approximately 9 cM on chromosome 5q31 that was further narrowed down to 2.14 cM, harboring 30 genes (logarithm of the odds [LOD] score 8.82 at q ¼ 0). All 30 genes were sequenced, revealing a single missense (p.Ser45Phe) mutation in UQCRQ (encoding ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5 kDa), one of the ten nuclear
    [Show full text]
  • Mutation of the Fumarase Gene in Two Siblings with Progressive Encephalopathy and Fumarase Deficiency T
    Mutation of the Fumarase Gene in Two Siblings with Progressive Encephalopathy and Fumarase Deficiency T. Bourgeron,* D. Chretien,* J. Poggi-Bach, S. Doonan,' D. Rabier,* P. Letouze,I A. Munnich,* A. R6tig,* P. Landneu,* and P. Rustin* *Unite de Recherches sur les Handicaps Genetiques de l'Enfant, INSERM U393, Departement de Pediatrie et Departement de Biochimie, H6pital des Enfants-Malades, 149, rue de Sevres, 75743 Paris Cedex 15, France; tDepartement de Pediatrie, Service de Neurologie et Laboratoire de Biochimie, Hopital du Kremlin-Bicetre, France; IFaculty ofScience, University ofEast-London, UK; and IService de Pediatrie, Hopital de Dreux, France Abstract chondrial enzyme (7). Human tissue fumarase is almost We report an inborn error of the tricarboxylic acid cycle, fu- equally distributed between the mitochondria, where the en- marase deficiency, in two siblings born to first cousin parents. zyme catalyzes the reversible hydration of fumarate to malate They presented with progressive encephalopathy, dystonia, as a part ofthe tricarboxylic acid cycle, and the cytosol, where it leucopenia, and neutropenia. Elevation oflactate in the cerebro- is involved in the metabolism of the fumarate released by the spinal fluid and high fumarate excretion in the urine led us to urea cycle. The two isoenzymes have quite homologous struc- investigate the activities of the respiratory chain and of the tures. In rat liver, they differ only by the acetylation of the Krebs cycle, and to finally identify fumarase deficiency in these NH2-terminal amino acid of the cytosolic form (8). In all spe- two children. The deficiency was profound and present in all cies investigated so far, the two isoenzymes have been found to tissues investigated, affecting the cytosolic and the mitochon- be encoded by a single gene (9,10).
    [Show full text]
  • The Regulation of Carbamoyl Phosphate Synthetase-Aspartate Transcarbamoylase-Dihydroorotase (Cad) by Phosphorylation and Protein-Protein Interactions
    THE REGULATION OF CARBAMOYL PHOSPHATE SYNTHETASE-ASPARTATE TRANSCARBAMOYLASE-DIHYDROOROTASE (CAD) BY PHOSPHORYLATION AND PROTEIN-PROTEIN INTERACTIONS Eric M. Wauson A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Pharmacology. Chapel Hill 2007 Approved by: Lee M. Graves, Ph.D. T. Kendall Harden, Ph.D. Gary L. Johnson, Ph.D. Aziz Sancar M.D., Ph.D. Beverly S. Mitchell, M.D. 2007 Eric M. Wauson ALL RIGHTS RESERVED ii ABSTRACT Eric M. Wauson: The Regulation of Carbamoyl Phosphate Synthetase-Aspartate Transcarbamoylase-Dihydroorotase (CAD) by Phosphorylation and Protein-Protein Interactions (Under the direction of Lee M. Graves, Ph.D.) Pyrimidines have many important roles in cellular physiology, as they are used in the formation of DNA, RNA, phospholipids, and pyrimidine sugars. The first rate- limiting step in the de novo pyrimidine synthesis pathway is catalyzed by the carbamoyl phosphate synthetase II (CPSase II) part of the multienzymatic complex Carbamoyl phosphate synthetase, Aspartate transcarbamoylase, Dihydroorotase (CAD). CAD gene induction is highly correlated to cell proliferation. Additionally, CAD is allosterically inhibited or activated by uridine triphosphate (UTP) or phosphoribosyl pyrophosphate (PRPP), respectively. The phosphorylation of CAD by PKA and ERK has been reported to modulate the response of CAD to allosteric modulators. While there has been much speculation on the identity of CAD phosphorylation sites, no definitive identification of in vivo CAD phosphorylation sites has been performed. Therefore, we sought to determine the specific CAD residues phosphorylated by ERK and PKA in intact cells.
    [Show full text]
  • Isocitrate Dehydrogenase Activity Assay Kit (MAK062)
    Isocitrate Dehydrogenase Activity Assay Kit Catalog Number MAK062 Storage Temperature –20 C TECHNICAL BULLETIN Product Description Developer 1 vl Isocitrate dehydrogenase (IDH) catalyzes the Catalog Number MAK062E conversion of isocitrate to -ketoglutarate. In eukaryotes, there are three isozymes of IDH, the IDH Positive Control (NADP+) 20 L mitochondrial IDH2 and IDH3, and the cytoplasmic/ Catalog Number MAK062F peroxisomal IDH1. All three IDH family members require the presence of a divalent cation (Mg2+ or Mn2+) NADH Standard, 0.5 mole 1 vl and either the electron-accepting cofactor NADP+ (IDH1 Catalog Number MAK062G and IDH2) or NAD+ (IDH3) for their enzymatic activity. IDH1 and IDH2 mutations resulting in neomorphic Reagents and Equipment Required but Not enzymatic activity are found in certain cancers such as Provided. glioblastoma, acute myeloid leukemia, and colon 96 well flat-bottom plate – It is recommended to use cancer. This neoactivity shows a change in the clear plates for colorimetric assays. substrate specificity resulting in the conversion of Spectrophotometric multiwell plate reader -ketoglutarate to 2-hydroxyglutarate. Mutations in IDH family members are also associated with Ollier disease Precautions and Disclaimer and Maffucci syndrome. This product is for R&D use only, not for drug, household, or other uses. Please consult the Material The Isocitrate Dehydrogenase Activity Assay kit Safety Data Sheet for information regarding hazards provides a simple and direct procedure for measuring and safe handling practices. + + + NADP -dependent, NAD -dependent, or both NADP + and NAD -dependent IDH activity in a variety of Preparation Instructions samples. IDH activity is determined using isocitrate as Briefly centrifuge vials before opening.
    [Show full text]
  • Emerging Regulatory Roles of Mitochondrial Sirtuins on Pyruvate Dehydrogenase Complex and the Related Metabolic Diseases: Review
    Biomedical Research and Therapy, 7(2):3645-3658 Open Access Full Text Article Review Emerging regulatory roles of mitochondrial sirtuins on pyruvate dehydrogenase complex and the related metabolic diseases: Review Abolfazl Nasiri1,2, Masoud Sadeghi3, Asad Vaisi-Raygani2,4, Sara Kiani3, Zahra Aghelan1,2, Reza Khodarahmi3,5,* ABSTRACT The pyruvate dehydrogenase complex (PDC) is a multi-enzyme complex of the mitochondria that provides a link between glycolysis and the Krebs cycle. PDC plays an essential role in producing Use your smartphone to scan this acetyl-CoA from glucose and the regulation of fuel consumption. In general, PDC enzyme is reg- QR code and download this article ulated in two different ways, end-product inhibition and posttranslational modifications (moreex- tensive phosphorylation and dephosphorylation subunit E1). Posttranslational modifications of this enzyme are regulated by various factors. Sirtuins are the class III of histone deacylatases that catalyze 1Students Research Committee, protein posttranslational modifications, including deacetylation, adenosine diphosphate ribosyla- Kermanshah University of Medical tion, and deacylation. Sirt3, Sirt4, and Sirt5 are mitochondrial sirtuins that control the posttrans- Sciences, Kermanshah, Iran lational modifications of mitochondrial protein. Considering the comprehensive role of sirtuins in post-translational modifications and regulation of metabolic processes, the aim of this review isto 2 Department of Clinical Biochemistry, explore the role of mitochondrial sirtuins in the regulation of the PDC. PDC deficiency is a com- School of Medicine, Kermanshah mon metabolic disorder that causes pyruvate to be converted to lactate and alanine rather than to University of Medical Sciences, Kermanshah, Iran acetyl-CoA. because this enzyme is in the gateway of complete oxidation, glucose products enter- ing the Krebs cycle and resulting in physiological and structural changes in the organs.
    [Show full text]
  • Part I Principles of Enzyme Catalysis
    j1 Part I Principles of Enzyme Catalysis Enzyme Catalysis in Organic Synthesis, Third Edition. Edited by Karlheinz Drauz, Harald Groger,€ and Oliver May. Ó 2012 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2012 by Wiley-VCH Verlag GmbH & Co. KGaA. j3 1 Introduction – Principles and Historical Landmarks of Enzyme Catalysis in Organic Synthesis Harald Gr€oger and Yasuhisa Asano 1.1 General Remarks Enzyme catalysis in organic synthesis – behind this term stands a technology that today is widely recognized as a first choice opportunity in the preparation of a wide range of chemical compounds. Notably, this is true not only for academic syntheses but also for industrial-scale applications [1]. For numerous molecules the synthetic routes based on enzyme catalysis have turned out to be competitive (and often superior!) compared with classic chemicalaswellaschemocatalyticsynthetic approaches. Thus, enzymatic catalysis is increasingly recognized by organic chemists in both academia and industry as an attractive synthetic tool besides the traditional organic disciplines such as classic synthesis, metal catalysis, and organocatalysis [2]. By means of enzymes a broad range of transformations relevant in organic chemistry can be catalyzed, including, for example, redox reactions, carbon–carbon bond forming reactions, and hydrolytic reactions. Nonetheless, for a long time enzyme catalysis was not realized as a first choice option in organic synthesis. Organic chemists did not use enzymes as catalysts for their envisioned syntheses because of observed (or assumed) disadvantages such as narrow substrate range, limited stability of enzymes under organic reaction conditions, low efficiency when using wild-type strains, and diluted substrate and product solutions, thus leading to non-satisfactory volumetric productivities.
    [Show full text]
  • Flavin-Containing Monooxygenases: Mutations, Disease and Drug Response Phillips, IR; Shephard, EA
    Flavin-containing monooxygenases: mutations, disease and drug response Phillips, IR; Shephard, EA For additional information about this publication click this link. http://qmro.qmul.ac.uk/jspui/handle/123456789/1015 Information about this research object was correct at the time of download; we occasionally make corrections to records, please therefore check the published record when citing. For more information contact [email protected] Flavin-containing monooxygenases: mutations, disease and drug response Ian R. Phillips1 and Elizabeth A. Shephard2 1School of Biological and Chemical Sciences, Queen Mary, University of London, Mile End Road, London E1 4NS, UK 2Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, UK Corresponding author: Shephard, E.A. ([email protected]). and, thus, contribute to drug development. This review Flavin-containing monooxygenases (FMOs) metabolize considers the role of FMOs and their genetic variants in numerous foreign chemicals, including drugs, pesticides disease and drug response. and dietary components and, thus, mediate interactions between humans and their chemical environment. We Mechanism and structure describe the mechanism of action of FMOs and insights For catalysis FMOs require flavin adenine dinucleotide gained from the structure of yeast FMO. We then (FAD) as a prosthetic group, NADPH as a cofactor and concentrate on the three FMOs (FMOs 1, 2 and 3) that are molecular oxygen as a cosubstrate [5,6]. In contrast to most important for metabolism of foreign chemicals in CYPs FMOs accept reducing equivalents directly from humans, focusing on the role of the FMOs and their genetic NADPH and, thus, do not require accessory proteins.
    [Show full text]
  • Deficiency of Skeletal Muscle Succinate Dehydrogenase and Aconitase
    Deficiency of skeletal muscle succinate dehydrogenase and aconitase. Pathophysiology of exercise in a novel human muscle oxidative defect. R G Haller, … , K Ayyad, C G Blomqvist J Clin Invest. 1991;88(4):1197-1206. https://doi.org/10.1172/JCI115422. Research Article We evaluated a 22-yr-old Swedish man with lifelong exercise intolerance marked by premature exertional muscle fatigue, dyspnea, and cardiac palpitations with superimposed episodes lasting days to weeks of increased muscle fatigability and weakness associated with painful muscle swelling and pigmenturia. Cycle exercise testing revealed low maximal oxygen uptake (12 ml/min per kg; healthy sedentary men = 39 +/- 5) with exaggerated increases in venous lactate and pyruvate in relation to oxygen uptake (VO2) but low lactate/pyruvate ratios in maximal exercise. The severe oxidative limitation was characterized by impaired muscle oxygen extraction indicated by subnormal systemic arteriovenous oxygen difference (a- v O2 diff) in maximal exercise (patient = 4.0 ml/dl, normal men = 16.7 +/- 2.1) despite normal oxygen carrying capacity and Hgb-O2 P50. In contrast maximal oxygen delivery (cardiac output, Q) was high compared to sedentary healthy men (Qmax, patient = 303 ml/min per kg, normal men 238 +/- 36) and the slope of increase in Q relative to VO2 (i.e., delta Q/delta VO2) from rest to exercise was exaggerated (delta Q/delta VO2, patient = 29, normal men = 4.7 +/- 0.6) indicating uncoupling of the normal approximately 1:1 relationship between oxygen delivery and utilization in dynamic exercise. Studies of isolated skeletal muscle mitochondria in our patient revealed markedly impaired succinate oxidation with normal glutamate oxidation implying a metabolic defect at […] Find the latest version: https://jci.me/115422/pdf Deficiency of Skeletal Muscle Succinate Dehydrogenase and Aconitase Pathophysiology of Exercise in a Novel Human Muscle Oxidative Defect Ronald G.
    [Show full text]
  • Isocitrate Dehydrogenase 1 (NADP+) (I5036)
    Isocitrate Dehydrogenase 1 (NADP+), human recombinant, expressed in Escherichia coli Catalog Number I5036 Storage Temperature –20 °C CAS RN 9028-48-2 IDH1 and IDH2 have frequent genetic alterations in EC 1.1.1.42 acute myeloid leukemia4 and better understanding of Systematic name: Isocitrate:NADP+ oxidoreductase these mutations may lead to an improvement of (decarboxylating) individual cancer risk assessment.6 In addition other studies have shown loss of IDH1 in bladder cancer Synonyms: IDH1, cytosolic NADP(+)-dependent patients during tumor development suggesting this may isocitrate dehydrogenase, isocitrate:NADP+ be involved in tumor progression and metastasis.7 oxidoreductase (decarboxylating), Isocitric Dehydrogenase, ICD1, PICD, IDPC, ICDC, This product is lyophilized from a solution containing oxalosuccinate decarboxylase Tris-HCl, pH 8.0, with trehalose, ammonium sulfate, and DTT. Product Description Isocitrate dehydrogenase (NADP+) [EC 1.1.1.42] is a Purity: ³90% (SDS-PAGE) Krebs cycle enzyme, which converts isocitrate to a-ketoglutarate. The flow of isocitrate through the Specific activity: ³80 units/mg protein glyoxylate bypass is regulated by phosphorylation of isocitrate dehydrogenase, which competes for a Unit definition: 1 unit corresponds to the amount of 1 common substrate (isocitrate) with isocitrate lyase. enzyme, which converts 1 mmole of DL-isocitrate to The activity of the enzyme is dependent on the a-ketoglutarate per minute at pH 7.4 and 37 °C (NADP formation of a magnesium or manganese-isocitrate as cofactor). The activity is measured by observing the 2 complex. reduction of NADP to NADPH at 340 nm in the 7 presence of 4 mM DL-isocitrate and 2 mM MnSO4.
    [Show full text]
  • Maturation of Sucrase-Isomaltase Complex in Human Fetal Small and Large Intestine During Gestation
    136 TRIADOU AND ZWEIBAUM 003 1-3998/85/190 1-0 136$02.0010 PEDIATRIC RESEARCH Vol. 19, No. 1, 1985 Copyright O 1985 International Pediatric Research Foundation, Inc Prin~edin U.S. A. Maturation of Sucrase-Isomaltase Complex in Human Fetal Small and Large Intestine during Gestation NICOLE TRIADOU AND ALAIN ZWEIBAUM UnitP de Recherches de GPnetique MPdicale [N. T.], INSERM U 12, H6pital des Enfants Malades, and Unite de Recherches sur le MPtabolisme et la Diffirmciation des Cellules en Culture [A.Z.],INSERM U 178, H6pital Broussais, Paris, France ABSTRACT. Sucrase-isomaltase complex is expressed in chromatography. The homogeneity of the preparation was as- human small intestine throughout gestation and in the large sessed by polyacrylamide gel electrophoresis and crossed immu- intestine between 12 and 30 wk. The molecular form of the noelectrophoresis against an antihuman brush-border antiserum enzyme was studied in the brush-border membrane frac- (12). Rabbits were immunized by sc injections at 15-day intervals tions by the immunoblotting method. Before 30 wk of with 0.2 mg of purified enzyme and bled 7 days after the fourth gestation, the enzyme is present only as the high molecular injection. Immunoglobulins G were prepared by ion exchange weight prosucrase-isomaltase, while from 30 wk until birth chromatography (10, 15). the two subunits are also present. The fetal enzyme, as its Brush-border separation, transjer, and identification of antigen. proform and as its two subunits, has a faster mobility in Preparations of the brush-border fractions of small and large sodium-dodecylsulfate polyacrylamide gel electrophoresis, intestine were obtained by the calcium precipitation method as than the adult enzyme (removal of sialic acid residues from previously described (12).
    [Show full text]
  • Elevation of Cardiac Glycolysis Reduces Pyruvate Dehydrogenase but Increases Glucose Oxidation
    University of Louisville ThinkIR: The University of Louisville's Institutional Repository Electronic Theses and Dissertations 5-2011 Elevation of cardiac glycolysis reduces pyruvate dehydrogenase but increases glucose oxidation. Qianwen Wang University of Louisville Follow this and additional works at: https://ir.library.louisville.edu/etd Recommended Citation Wang, Qianwen, "Elevation of cardiac glycolysis reduces pyruvate dehydrogenase but increases glucose oxidation." (2011). Electronic Theses and Dissertations. Paper 1519. https://doi.org/10.18297/etd/1519 This Doctoral Dissertation is brought to you for free and open access by ThinkIR: The University of Louisville's Institutional Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the author, who has retained all other copyrights. For more information, please contact [email protected]. ELEVATION OF CARDIAC GLYCOLYSIS REDUCES PYRUVATE DEHYDROGENASE BUT INCREASES GLUCOSE OXIDATION By Qianwen Wang B.S., Guangdong Medical College of China, 1999 M.S., University of Louisville, 2006 A Dissertaion Submitted to the Faculty of the Graduate School of the University of Louisville In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Department of Physiology and Biophysics University of Louisville, School of Medicine Louisville, Kentucky May 2011 ELEVATION OF CARDIAC GLYCOLYSIS REDUCES PYRUVATE DEHYDROGENASE BUT INCREASES GLUCOSE OXIDATION By Qianwen Wang B.S., Guangdong Medical College of China, 1999 M.S., University of Louisville, 2006 A Dissertation Approved on March 28, 2011 by the following Dissertation Committee: Dissertation Director-Paul N. Epstein, Ph.D. William B.
    [Show full text]